-
6 Comments
Stryker Corporation is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.4.
Stryker Corporation's total revenue rose by 3.2% to $4B since the same quarter in the previous year.
Its net income has increased by 27.3% to $923M since the same quarter in the previous year.
Finally, its free cash flow fell by 382.6% to $-2B since the same quarter in the previous year.
Based on the above factors, Stryker Corporation gets an overall score of 4/5.
Golden Gate Sings
Follow
3 years, 3 months ago
|
Golden Gate Sings
Follow
3 years, 3 months ago
|
TradeWithAlerts
Follow
3 years, 3 months ago
|
Panna Montana
Follow
3 years, 3 months ago
|
TradeWithAlerts
Follow
3 years, 3 months ago
|
Sector | Healthcare |
---|---|
Industry | Medical Devices |
ISIN | US8636671013 |
CurrencyCode | USD |
Exchange | NYSE |
PE Ratio | 47.02 |
---|---|
Dividend Yield | 1.0% |
Target Price | 285.22 |
Beta | 0.93 |
Market Cap | 110B |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SYK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024